SEARCH BY
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Life Science |
| Employees | 82,878 |
| Revenue | 44.3B EUR (2024) |
Sanofi is a French multinational pharmaceutical company. Sanofi was founded in 1994 and is based in Paris, France.
| DEAL STATS | # |
|---|---|
| Overall | 20 of 30 |
| Sector: Life Science M&A | 11 of 21 |
| Type: Add-on Acquisition M&A Deals | 15 of 24 |
| Country: Belgium M&A | 1 of 1 |
| Year: 2018 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-06-18 |
Sanofi SA - Infectious diseases
Paris, France Sanofi SA - Infectious diseases are caused by bacteria, viruses, fungi or parasites and can be spread, directly or indirectly, from one person to another. Treatments for infectious diseases include antibiotics and anti-viral medications. Today, infectious diseases propagated by bacteria are becoming increasingly resistant to many antibiotics and any use of antibiotics reduces the effectiveness of these drugs for other patients. The World Health Organization (“WHO”) has deemed antibiotic resistance to be one of the three greatest threats to human health today. Almost a million people die of resistant infections a year. It is also estimated that by 2050, 10 million lives a year and a cumulative 100 trillion dollars of economic output are at risk due to the rise of drug resistant infections, if solutions to this problem are not identified now. Thus, there is a critical need to research and develop medical solutions to combat antibiotic resistant bacteria. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-10-01 |
Sanofi SA - Inhalation Contract Manufacturing Business
Paris, France Sanofi SA - Inhalation Contract Manufacturing Business which includes development and manufacturing capabilities for novel respiratory products. Business including a manufacturing facility located in Holmes Chapel, UK. |
Sell | - |
